Steigerwald, Gordon & Koch Inc. Abb Vie Inc. Transaction History
Steigerwald, Gordon & Koch Inc.
- $908 Million
- Q3 2024
A detailed history of Steigerwald, Gordon & Koch Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Steigerwald, Gordon & Koch Inc. holds 3,345 shares of ABBV stock, worth $633,710. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,345
Previous 3,244
3.11%
Holding current value
$633,710
Previous $556,000
18.71%
% of portfolio
0.07%
Previous 0.07%
Shares
17 transactions
Others Institutions Holding ABBV
# of Institutions
3,757Shares Held
1.28BCall Options Held
13MPut Options Held
9.84M-
Vanguard Group Inc Valley Forge, PA171MShares$32.3 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.8 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$14.7 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.1 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.31 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $335B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...